NASDAQ · CRIS
Curis, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CRIS: Nov 5, 2026
Curis, Inc. Common Stock is estimated to report earnings on 11/05/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-2.29. The reported EPS for the same quarter last year was $-9.8.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-2.29 | $-2.29 | $-2.29 | 1 |
| Dec 2026 | $-1.50 | $-1.50 | $-1.50 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · The Motley Fool · Zacks · Quiver Quantitative- RTTNews · Aug 13, 10:28 AM EDTCuris Prices $5.6 Million Offering Of Shares And Warrants; Stock Up(RTTNews) – Curis, Inc. (CRIS) on Thursday priced its public offering with certain new and existing healthcare-focused institutional investors for the purchase and sale of 3.733 million shares or pre-funded warrants and accompanying warrants to purchase up to 3.733 million shares
- The Motley Fool · Jun 2, 1:20 PM EDTCuris (CRIS) Q1 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · May 7, 11:15 AM EDTVericel Corporation (VCEL) Reports Q1 Loss, Beats Revenue EstimatesVericel (VCEL) delivered earnings and revenue surprises of +17.24% and +7.25%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Apr 28, 8:45 AM EDTKiniksa Pharmaceuticals International, plc (KNSA) Tops Q1 Earnings and Revenue EstimatesKiniksa Pharmaceuticals International, plc (KNSA) delivered earnings and revenue surprises of +50.00% and +5.24%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Apr 15, 12:00 PM EDTCuris (CRIS) Upgraded to Buy: What Does It Mean for the Stock?Curis (CRIS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- The Motley Fool · Mar 19, 5:37 PM EDTCuris (CRIS) Q4 2025 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Dec 10, 11:49 PM ESTAfter-Hours Gainers: Biotech Stocks Climb On Data Anticipation And Momentum Buying(RTTNews) – U.S. after-hours trading on Wednesday saw a wave of gains across several small-cap and micro-cap biotech names, with a mix of catalyst-driven moves and sentiment-based rebounds. While a few companies advanced on upcoming clinical milestones or recent data presentation
- Zacks · Nov 6, 5:10 PM ESTCuris (CRIS) Reports Q3 Loss, Beats Revenue EstimatesCuris (CRIS) delivered earnings and revenue surprises of +20.97% and +8.58%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
- The Motley Fool · Aug 5, 6:10 PM EDTCuris (CRIS) Q2 Loss Narrows 66%GAAP loss per share of $0.68 beat the analyst estimate by 50% in Q2 2025, and the GAAP net loss narrowed compared to the prior year.
- Zacks · Aug 5, 9:10 AM EDTCuris (CRIS) Reports Q2 Loss, Beats Revenue EstimatesCuris (CRIS) delivered earnings and revenue surprises of +65.83% and +14.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
- Quiver Quantitative · May 7, 5:06 PM EDTCURIS Earnings Preview: Recent $CRIS Insider Trading, Hedge Fund Activity, and MoreCURIS ($CRIS) is expected to release its quarterly earnings data on Friday, May 9th before market open, per Finnhub. Analysts are expecting revenue of $2,647,920 and earnings of -$1.21 per share.
- Zacks · May 6, 9:05 AM EDTCuris (CRIS) Reports Q1 Loss, Tops Revenue EstimatesCuris (CRIS) delivered earnings and revenue surprises of -9.65% and 11.74%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Curis, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.